[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.207.116. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 713
Citations 0
Viewpoint
December 2015

Breast Cancer Screening in Elderly WomenPrimum Non Nocere

Author Affiliations
  • 1Division of Surgical Oncology and Endocrine Surgery, University of Texas Health Science Center, San Antonio
  • 2Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
JAMA Surg. 2015;150(12):1107-1108. doi:10.1001/jamasurg.2015.2663

In elderly women (defined here as those 70 years and older), screening mammography may do more harm than good, and we believe that screening clinical breast examination (CBE) should be evaluated as an alternative. Indeed, when considering breast cancer screening in elderly women, one should recall a key principle of bioethics, primum non nocere (first, do no harm). Mammography is a sensitive screening test, and this sensitivity exposes elderly women to substantial harms (ie, false-positives, lead time, and overdiagnosis).1 Moreover, in older women, the effect of mammography screening on breast cancer mortality remains uncertain, as there are very limited data from randomized trials. Yet, advancing age is the single greatest risk factor for the development of breast cancer in women, and large numbers of American women continue to obtain annual screening mammograms beyond age 70 years.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×